415 Capital is a Munich-based specialist venture capital firm dedicated to breakthrough medical technology, investing €5-15 million per company at clinical-through-commercial stage across Europe, Israel and North America. The investment team is led by General Partners Frederik Groenewegen and David Thompson, and includes a dedicated clinical team of physicians and clinical specialists.
The firm h...
United States
Geneva, Switzerland
London, United Kingdom
Ann Arbor, Michigan, United States
United Kingdom
New York, United States